Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety

被引：32

作者：

Hogg, Sandy ^{[1
]}

Michan, Line ^{[1
]}

Jessa, Maria ^{[1
]}

机构：

[1] H Lundbeck & Co AS, Dept Psychopharmacol, DK-2500 Copenhagen, Denmark

来源：

NEUROPHARMACOLOGY | 2006年 / 51卷 / 01期

关键词：

escitalopram; SSRI; panic; anxiety; rat; 5-HT;

D O I：

10.1016/j.neuropharm.2006.03.009

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Escitalopram, the active enantiomer of the selective serotonin reuptake inhibitor (SSRI) citalopram, has effects in animal models for the detection of antidepressant and anxiolytic effect and in patients with major depressive and anxiety disorders. In the present study, the effects of escitalopram in the dorsal periaqueductal grey (dPAG) stimulation model of panic anxiety were investigated and compared to a number of clinically used anti-panic agents. The SSRIs, citalopram (ED50 6.6 mg/kg), fluoxetine (ED50 13.6 mg/kg), paroxetine (ED50 2.9 mg/kg) and the benzodiazepine ligand, alprazolam (ED50 0.3 mg/kg) all reduced the flight-like escape behaviour produced by electrical stimulation of the dPAG in the rat, this is presumed to indicate a reduction in fear and/or physical sensation and is interpreted as an anti-panic effect of the drugs. Escitalopram (ED50 3.1 mg/kg) also significantly reduced flight behaviour indicating the anti-panic potential of the compound; it is suggested that escitalopram will be twice as potent as citalopram in this context. (c) 2006 Elsevier Ltd. All rights reserved.

引用

页码：141 / 145

页数：5

共 28 条

[11] 5-HT1C RECEPTORS IN THE SEROTONERGIC CONTROL OF PERIAQUEDUCTAL GRAY INDUCED AVERSION IN RATS [J].

JENCK, F ;

BROEKKAMP, CLE ;

VANDELFT, AML .

PSYCHOPHARMACOLOGY, 1990, 100 (03) :372-376

[12] Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors [J].

Kasper, S ;

Resinger, E .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (04) :307-321

[13] VALPROATE TREATMENT OF PANIC DISORDER AND LACTATE-INDUCED PANIC ATTACKS [J].

KECK, PE ;

TAYLOR, VE ;

TUGRUL, KC ;

MCELROY, SL ;

BENNETT, JA .

BIOLOGICAL PSYCHIATRY, 1993, 33 (07) :542-546

[14]

LESSER IM, 1988, ARCH GEN PSYCHIAT, V45, P437

[15]

MITCHELL PJ, UNPUB INT J NEUROPSY

[16]

MODIGH K, 1992, J CLIN PSYCHOPHARM, V12, P251

[17]

Montgomery SA, 2003, NORD J PSYCHIAT, V57, P103

[18] Escitalopram (S-Enantiomer of citalopram):: Clinical efficacy and onset of action predicted from a rat model [J].

Montgomery, SA ;

Loft, H ;

Sánchez, C ;

Reines, EH ;

Papp, M .

PHARMACOLOGY & TOXICOLOGY, 2001, 88 (05) :282-286

[19] The R-enantiomer of citalopram increase in extracellular 5-HT counteracts escitalopram-induced in the frontal cortex of freely moving rats [J].

Mork, A ;

Kreilgaard, M ;

Sánchez, C .

NEUROPHARMACOLOGY, 2003, 45 (02) :167-173

[20] SENSATIONS EVOKED BY STIMULATION IN MIDBRAIN OF MAN [J].

NASHOLD, BS ;

WILSON, WP ;

SLAUGHTER, DG .

JOURNAL OF NEUROSURGERY, 1969, 30 (01) :14-+

← 1 2 3 →